Madagascar’s Drug Sets For Review By NAFDAC, NIPRD, NIMR

0
117
4

Federal Government of Nigeria’ health agencies and the National Agency for Food and Drug Administration Control (NAFDAC) have received Madagascar’s COVID-19 treatment drug for evaluation.

The samples were brought to the country on May 16 by Guinea Bissau President Umaro Sissoco Embaló.

Minister of health Dr. Osagie Ehanire said on Thursday that the samples were found to be in two varieties  – one for prevention, the other for treatment.

The other government agencies that also got samples of “COVID Organics” are:  National Institute for Pharmaceutical Research and Development (NIPRD), and Nigerian Institute of Medical Research (NIMR).

READ:  457 Of The Novel Coronavirus Recorded In Nigeria, Total Infections Now 44,890

The herbal solution will be thoroughly x-rayed and analysed by the agencies to determine the constituents, toxicological, and efficacy.

Dr. Ehanire said: “Global efforts to find a cure for COVID-19, in which Nigeria is participating in the WHO solidarity trial, will be reviewed by our panel of experts, as WHO suspended the trial, due to alarm raised by a medical journal, on the safety of some drugs being tried, like hydroxychloroquine, chloroquine and their combinations.

READ:  389 New COVID-19 Cases, Recorded In Nigeria,Total Infections Hit 8,733

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here